Table 1. Compared with your training NOW, how much educational attention should the topic of informed consent receive (Mean ±SD).

	Gender		Overall (N = 108)
Chronbach’s α 0.915	Female (N = 84)	Male(N = 24)	Male and Female
1. Deciding how much clinical information to share with patients	7.00±1.53	6.83±1.52	6.96±1.52
2. Deciding when to withhold information from patients	6.82±1.79	6.13±2.09	6.66±1.87
3. Discussing risks, benefits and alternatives to the recommended treatment with patients	7.40±1.47	7.17±1.34	7.34±1.44
4. Obtaining informed consent from patients who are capable of making decisions	7.06±1.70	6.79±1.67	7.00±1.69
5. Obtaining informed consent from patients whose decisional capacity is compromised	7.11±1.66	6.48±1.53	6.97±1.65
6. Obtaining informed consent from non-Arabic speaking patients	7.04±1.60	6.54±1.53	6.93±1.59
7. Obtaining informed refusal from patients who decline recommended treatment	7.22±1.50	6.50±1.79	7.06±1.59
8. Obtaining informed consent or refusal from surrogate decision-makers	7.18±1.54	6.75±1.68	7.08±1.57
9. Conducting assessments of decision- making capacity	7.39±1.55	6.96±2.05	7.29±1.67
Group means	7.19±1.23	6.67±1.21	7.07±1.24

Rated on a scale from 1 ‘‘much less” to 5 ‘‘same” to 9 ‘‘much more” attention needed compared to now.